XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.2
Business Combinations and Asset Acquisitions (Tables)
6 Months Ended
Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Schedule of Columbia and UHC common stock
The table below summarizes the ownership of the combined company, Columbia, following the Merger, as well as the market capitalization of the combined company using shares of Columbia and UHC common stock outstanding at February 28, 2023 and Columbia’s closing price on February 28, 2023.
Columbia Ownership and Market Value Table
(Pro Forma)
(in thousands)Number of UHC Outstanding SharesPercentage Ownership
Market Value at $29.73 Columbia Share Price
Columbia shareholders78,863 37.9 %$2,344,600 
UHC shareholders129,378 62.1 %3,846,408 
Total208,241 100.0 %$6,191,008 
Schedule of hypothetical number of shares
Next, the hypothetical number of shares UHC would have to issue to give Columbia shareholders the same percentage ownership in the combined company is calculated in the table below (based on shares of UHC common stock outstanding at February 28, 2023):
Hypothetical UHC Ownership
(in thousands)Number of UHC Outstanding SharesPercentage Ownership
Columbia shareholders132,365 37.9 %
UHC shareholders217,150 62.1 %
Total349,515 100.0 %
Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable
Finally, the purchase price for purposes of the transaction accounting adjustments is calculated based on the number of hypothetical shares of UHC common stock issued to Columbia shareholders, multiplied by the share price as demonstrated in the table below (amounts in thousands except per share data):
Number of hypothetical UHC common shares issued to Columbia shareholders132,365 
UHC market price per share as of February 28, 2023
$17.66 
Purchase price determination of hypothetical UHC shares issued to Columbia shareholders$2,337,567 
Value of Columbia RSUs hypothetically converted to shares1,646 
Cash in lieu of fractional shares65 
Purchase price consideration$2,339,278 
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed
(in thousands)
February 28, 2023
Purchase price consideration
Total merger consideration$2,339,278 
Fair value of assets acquired:
Cash and due from banks$274,587 
Investment securities6,226,102 
Loans held for sale2,358 
Loans and leases, net of allowance for loan and lease losses10,884,218 
Restricted equity securities101,760 
Premises and equipment203,270 
Other intangible assets710,230 
Deferred tax asset, net256,288 
Other assets571,773 
Total assets acquired$19,230,586 
Fair value of liabilities assumed:
Deposits$15,193,474 
Securities sold under agreements to repurchase70,025 
Borrowings2,294,360 
Junior and other subordinated debentures20,310 
Other liabilities342,373 
Total liabilities assumed$17,920,542 
Net assets acquired$1,310,044 
Goodwill$1,029,234 
Disclosure detail of reconciliation of difference between purchase price and par The following table provides a summary of these PCD loans at acquisition:
(in thousands)
February 28, 2023
Principal of PCD loans acquired$478,648 
PCD ACL at acquisition(26,492)
Non-credit discount on PCD loans(49,337)
Fair value of PCD loans$402,819 
Business acquisition, merger related expense
The following table shows the impact of the merger-related expenses for the periods indicated:
Three Months EndedSix Months Ended
(in thousands)June 30, 2023June 30, 2022June 30, 2023June 30, 2022
Legal and professional$5,108 $2,531 $54,527 $3,530 
Personnel8,761 38 30,215 1,310 
Premises and equipment14,010 57 35,275 57 
Charitable contributions— — 20,000 — 
Other1,770 46 5,530 53 
Total merger-related expenses$29,649 $2,672 $145,547 $4,950 
Business Acquisition, Pro Forma Information
Unaudited Pro Forma for the
Six Months Ended
(in thousands)
June 30, 2023
June 30, 2022
Net interest income$1,014,447 $959,039 
Non-interest income$128,250 $179,091 
Net income (1)
$381,212 $185,660 
(1) The 2023 pro forma net income was adjusted to exclude $173.5 million of merger-related costs, inclusive of historical Columbia merger related costs, incurred in 2023 and the 2022 pro forma net income was adjusted to include these costs.